FNY Investment Advisers’s 89bio ETNB Stock Holding History

FNY Investment Advisers’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-61,900	Closed	-$909K	–	1084
2025 Q3	$909K	Buy	+61,900	New	+$631K	0.29%	105
2025 Q2	–	Sell	-3,000	Closed	-$21K	–	1023
2025 Q1	$21K	Buy	+3,000	New	+$26.2K	0.01%	395
2024 Q1	–	Sell	-2,000	Closed	-$22K	–	715
2023 Q4	$22K	Buy	+2,000	New	+$18.4K	0.02%	255
2023 Q2	–	Sell	-300	Closed	-$4K	–	577
2023 Q1	$4K	Buy	+300	New	+$3.91K	﹤0.01%	412

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FNY Investment Advisers's ETNB Position: Q4 2025 in Review

FNY Investment Advisers sold out of 89bio (ETNB) in Q4 2025, closing a stake of 61,900 shares — an estimated $909K sold.

FNY Investment Advisers first reported a position in ETNB in Q1 2023 and held it in 4 quarters. The position peaked at $909K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

FNY Investment Advisers reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
FNY Investment Advisers sold 61,900 89bio shares in Q4 2025, an estimated $909K.
FNY Investment Advisers first reported a position in 89bio in Q1 2023 and held it in 4 quarters.
FNY Investment Advisers's 89bio position peaked at $909K in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.